Growth hormone heterogeneity: genes, isohormones, variants, and binding proteins
- PMID: 1760996
- DOI: 10.1210/edrv-12-4-424
Growth hormone heterogeneity: genes, isohormones, variants, and binding proteins
Abstract
Human GH represents a family of proteins rather than a single hormone. The circulation contains a bewildering array of GH forms, including several monomeric variants, their homo- and heteropolymers, fragments, and complexes with at least two BPs. The net biological activity of this mixture is difficult to predict, as the various molecular forms interact as partial agonists and/or antagonists at the receptor level. The number of GH forms that can be counted in plasma exceeds 100. Table 5 attempts to illustrate what is known and provide estimates for circulating variants. It does not include GH-V and its variants, which have to be added in pregnancy. Of note, what is commonly understood as "plasma GH," i.e. free monomeric 22K, represents only 21% of total immunoreactivity in plasma. In view of this complicated picture, it should be no surprise that different assays of plasma GH yield different results (107, 108, 290). While immunoassays are relatively unaffected by the BPs (291), receptor assays are seriously affected by the high affinity BP (261). Immunoassays, particularly of the monoclonal variety, are vulnerable to differential recognition of molecular variants depending on the unique epitope specificity of the antibody used. Polyclonal assays are more robust in this regard because of "epitope averaging" among the wide spectrum of epitope specificities present in the antibody population. Future work should aim at developing antibodies that are specific for individual GH variants. Such molecular probes will be helpful not only in standardizing immunoassays, but also in delineating the biological role of the various GH forms. The physiological significance of the numerous GH forms (or of the BPs) is still largely unknown. Progress in this area has been hampered, on the one hand, by the unavailability of pure GH variants in quantities sufficient for biological studies, and, on the other, by a certain lack of interest stemming from suspicions about artifacts. The recent resurgence of interest in GH and in its receptor and BPs should also refocus attention on the various molecular forms. Thus far, this interest has been largely confined to monomeric 22K, which is certainly effective for its original intended purpose, namely growth promotion. Whether 22K is sufficient for optimal growth and development, or whether it can fulfill all the functions of the GH family is unknown. It can be argued that evolutionarily conserved GH variants probably have biological importance.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Growth hormone isoforms.Growth Horm IGF Res. 2009 Aug;19(4):333-40. doi: 10.1016/j.ghir.2009.04.011. Epub 2009 May 24. Growth Horm IGF Res. 2009. PMID: 19467614 Review.
-
Metabolism of growth hormone (GH) and different molecular forms of GH in biological fluids.Horm Res. 1991;36 Suppl 1:5-10. doi: 10.1159/000182179. Horm Res. 1991. PMID: 1806486 Review.
-
Identification of placental human growth hormone as the growth hormone-V gene expression product.J Clin Endocrinol Metab. 1990 Jul;71(1):15-8. doi: 10.1210/jcem-71-1-15. J Clin Endocrinol Metab. 1990. PMID: 2196278
-
The physiology of growth hormones (GHs) in pregnant women and partial characterization of the placental GH variant.J Clin Endocrinol Metab. 1988 Jun;66(6):1171-80. doi: 10.1210/jcem-66-6-1171. J Clin Endocrinol Metab. 1988. PMID: 3372680
-
Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationships with growth hormone and IGFs and physiological significance.J Clin Endocrinol Metab. 1989 Dec;69(6):1291-301. doi: 10.1210/jcem-69-6-1291. J Clin Endocrinol Metab. 1989. PMID: 2555386
Cited by
-
Growth hormone release during acute and chronic aerobic and resistance exercise: recent findings.Sports Med. 2002;32(15):987-1004. doi: 10.2165/00007256-200232150-00003. Sports Med. 2002. PMID: 12457419 Review.
-
Influence of the high-affinity growth hormone (GH)-binding protein on plasma profiles of free and bound GH and on the apparent half-life of GH. Modeling analysis and clinical applications.J Clin Invest. 1993 Feb;91(2):629-41. doi: 10.1172/JCI116243. J Clin Invest. 1993. PMID: 8432866 Free PMC article.
-
Ghrelin stimulation of growth hormone isoforms: parallel secretion of total and 20-kDa growth hormone and relation to insulin sensitivity in healthy humans.J Clin Endocrinol Metab. 2012 Sep;97(9):3366-74. doi: 10.1210/jc.2012-2012. Epub 2012 Jun 28. J Clin Endocrinol Metab. 2012. PMID: 22745239 Free PMC article. Clinical Trial.
-
Dose dependency of the serum bio/immuno GH ratio in children during pharmacological secretion tests.J Endocrinol Invest. 2006 Feb;29(2):109-14. doi: 10.1007/BF03344082. J Endocrinol Invest. 2006. PMID: 16610235
-
Exercise modulation of growth hormone isoforms: current knowledge and future directions for the exercise endocrinologist.Br J Sports Med. 2007 Jun;41(6):346-8; discussion 348. doi: 10.1136/bjsm.2006.028951. Epub 2007 Jan 19. Br J Sports Med. 2007. PMID: 17237119 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources